Tecogen (TGEN) director Earl Lewis receives stock options on 25,000 shares
Rhea-AI Filing Summary
Tecogen Inc. director Earl Lewis reported a stock option grant for 25,000 shares of common stock. The option has an exercise price of $5.17 per share and vests in equal 25% installments each year. It expires on June 26, 2036, and this grant brings his directly held derivative position to 25,000 options.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Lewis Earl
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 25,000 | $5.17 | $129K |
Holdings After Transaction:
Stock Option (Right to Buy) — 25,000 shares (Direct)
Footnotes (1)
- F1. Vests 25% per year
Key Figures
Options granted: 25,000 options
Exercise price: $5.17 per share
Underlying shares: 25,000 shares
+2 more
5 metrics
Options granted
25,000 options
Stock Option (Right to Buy) grant to director
Exercise price
$5.17 per share
Stock option conversion or exercise price
Underlying shares
25,000 shares
Underlying common stock tied to option grant
Expiration date
June 26, 2036
Option expiration
Post-grant derivative holdings
25,000 options
Total derivative securities following transaction
Key Terms
Stock Option (Right to Buy), Common Stock, Grant, award, or other acquisition, Vests 25% per year
4 terms
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
Common Stock financial
"underlying_security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Grant, award, or other acquisition financial
"transaction_code_description: "Grant, award, or other acquisition""
Vests 25% per year financial
"footnote text: "Vests 25% per year""
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did Tecogen (TGEN) director Earl Lewis report in this Form 4?
Earl Lewis reported receiving a stock option grant for 25,000 Tecogen shares. The options allow him to buy common stock at a fixed price, reflecting equity-based compensation rather than an open-market purchase or sale of existing shares.
What is the exercise price of Earl Lewis’s Tecogen stock options?
The stock options have an exercise price of $5.17 per Tecogen share. This means Lewis can purchase common stock at that price once options vest, regardless of the market price at exercise, subject to the grant’s terms.
How do Earl Lewis’s Tecogen options vest over time?
The options vest at 25% per year according to the footnote. This creates a four-year vesting schedule, encouraging longer-term alignment with Tecogen’s performance as more options become exercisable each year he continues in service.
When do Earl Lewis’s Tecogen stock options expire?
The options expire on June 26, 2036. After that expiration date, any unexercised options become worthless, so the economic value depends on Tecogen’s share price before that time and whether the options are in the money.
How many Tecogen derivative securities does Earl Lewis hold after this grant?
After this grant, Lewis directly holds 25,000 stock options linked to Tecogen common shares. These options represent potential future ownership if exercised and are separate from any existing or future holdings of Tecogen common stock itself.